Skip to main content

Teladoc Health Inc

For the period ended Dec 31, 2023. Filed Feb 23, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 23, 2024

TDOC$8.98+2.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I
Special Note Regarding Forward Looking Statements3
ITEM 1.Business3
ITEM 1A.Risk Factors18
ITEM 1B.Unresolved Staff Comments50
ITEM 1C.Cybersecurity50
ITEM 2.Properties51
ITEM 3.Legal Proceedings52
ITEM 4.Mine Safety Disclosures52
PART II
ITEM 5.Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities52
ITEM 6.Reserved53
ITEM 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations54
ITEM 7A.Quantitative and Qualitative Disclosures About Market Risk68
ITEM 8.Financial Statements and Supplementary Data69
ITEM 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure69
ITEM 9A.Controls and Procedures69
ITEM 9B.Other Information72
ITEM 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections72
PART III
ITEM 10.Directors, Executive Officers and Corporate Governance72
ITEM 11.Executive Compensation72
ITEM 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters72
ITEM 13.Certain Relationships and Related Transactions, and Director Independence73
ITEM 14.Principal Accounting Fees and Services73
PART IV
ITEM 15.Exhibits and Financial Statement Schedules74
EXHIBIT INDEX75
SIGNATURES80
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTAL DATAF-1
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.